BioCentury This Week
Episodes
Ep. 66 - Biotechs hit 3Q with Coolers Full of Cash; plus Distillery on Tap
06 Jul 2021
Contributed by Lukas
Reach us by sending a text
Ep. 65 - Optimism for Intellia's CRISPR Breakthrough, Concerns about Aduhelm
29 Jun 2021
Contributed by Lukas
Reach us by sending a text
Ep. 64 - Amyloid Analysis: Stress Testing FDA's Logic on Surrogate Endpoint
24 Jun 2021
Contributed by Lukas
Reach us by sending a text
Ep. 63 - Woodcock, Noubar and Genmab’s dealmaking: A BioCentury Podcast
21 Jun 2021
Contributed by Lukas
Reach us by sending a text
Ep. 62 - Reflecting on the Implications of Aduhelm's Approval: A BioCentury Podcast
14 Jun 2021
Contributed by Lukas
Reach us by sending a text
Ep. 61 - Dissecting FDA's Aducanumab Decision
08 Jun 2021
Contributed by Lukas
Reach us by sending a text
Ep. 60 - D-Day for Aducanumab: What's at stake
02 Jun 2021
Contributed by Lukas
Reach us by sending a text
Ep. 59 - KRAS to the Future; plus ARPA-H & EGFR
02 Jun 2021
Contributed by Lukas
Reach us by sending a text
Ep. 58 - LAG3 Before You Leap; plus BEE21, G20 Highlights
24 May 2021
Contributed by Lukas
Reach us by sending a text
Ep. 57 - Financing Scandinavia; plus IP Waivers, Long Covid & AAV Pays
10 May 2021
Contributed by Lukas
Reach us by sending a text
Ep. 56 - FDA’s ODAC Bind; plus NK Cell Engagers and Company Creation in Europe
04 May 2021
Contributed by Lukas
Reach us by sending a text
Ep. 55 - German Plays Deliver on Data, plus Accelerated Approval on Trial
27 Apr 2021
Contributed by Lukas
Reach us by sending a text
Ep. 54 - Patient Groups’ Pandemic Pain; plus Voters’ Rights and Synthetic Lethality
20 Apr 2021
Contributed by Lukas
Reach us by sending a text
Ep. 53 - Competence & Continuity at CDER; plus BIO 3.0, AACR and 2Q Preview
13 Apr 2021
Contributed by Lukas
Reach us by sending a text
Ep. 52 - Memories of John Martin, plus AACR's Hot Targets & Bio€quity Europe Preview
06 Apr 2021
Contributed by Lukas
Reach us by sending a text
Ep. 51 - Abernethy & the Obvious at FDA; Plus CEPI & EpimAb
30 Mar 2021
Contributed by Lukas
Reach us by sending a text
Ep. 50 - FTC & the Zombie Pharma Dinosaurs; Plus: RIP José Baselga, NCATS & SPACs
23 Mar 2021
Contributed by Lukas
Reach us by sending a text
Ep. 49 - Vaccine Vexed; Plus Assessing Lilly's Alzheimer's Data & PDUFA Preview
16 Mar 2021
Contributed by Lukas
Reach us by sending a text
Ep. 48 - New Modality Deep Dive; plus Sharpless Speaks & Five Prime Scores
09 Mar 2021
Contributed by Lukas
Reach us by sending a text
Ep. 47 - Whither Woodcock; plus Refresh for German Biotech & Modalities to Market
02 Mar 2021
Contributed by Lukas
Reach us by sending a text
Ep. 46 - Pipeline plays for BMS, Rigel; plus J&J's vaccine panel & access for Africa
23 Feb 2021
Contributed by Lukas
Reach us by sending a text
Ep. 45 - Start-Up Trends, COVID Variants and J&J's Adcomm
17 Feb 2021
Contributed by Lukas
Reach us by sending a text
Ep. 44 - Biotech's IPO blizzard, plus GameStop, Porter Report & Vaccine Guidance
09 Feb 2021
Contributed by Lukas
Reach us by sending a text
Ep. 43 - Europe's Next Act & the Porter Report
02 Feb 2021
Contributed by Lukas
Reach us by sending a text
Ep. 42 - Warp Speed Reflections, Master Protocols & Biden’s COVID Plan
25 Jan 2021
Contributed by Lukas
Reach us by sending a text
Ep. 41 - Biden's Science Team; Plus: Early Cancer Detection
20 Jan 2021
Contributed by Lukas
Reach us by sending a text
Ep. 40 - Investors' Picks & Access to Capital in 2021
15 Jan 2021
Contributed by Lukas
Reach us by sending a text
Ep. 39 - COVID Accountability, Biden's Bidding & Start-up Season
12 Jan 2021
Contributed by Lukas
Reach us by sending a text
Ep. 38 - Crucible of COVID, Ahoy 2021 & Cancer Deal Trends
05 Jan 2021
Contributed by Lukas
Reach us by sending a text
Ep. 37 - 2020's Silver Linings, New Year's Hopes
29 Dec 2020
Contributed by Lukas
Reach us by sending a text
Ep. 36 - Vaccines march forward & CAR Ts move earlier: a BioCentury podcast
15 Dec 2020
Contributed by Lukas
Reach us by sending a text
Ep. 35 - ASH Monday, Biden's Picks & Vaccine Conundrums
08 Dec 2020
Contributed by Lukas
Reach us by sending a text
Ep. 34 - Moderna Moves & Immunocore Breaks Through
01 Dec 2020
Contributed by Lukas
Reach us by sending a text
Ep. 33 - ASH Preview & Long Shot Drug Pricing Rule
24 Nov 2020
Contributed by Lukas
Reach us by sending a text
Ep. 32 - Moderna Times & China's Future
17 Nov 2020
Contributed by Lukas
Reach us by sending a text
Ep. 31 - Pfizer & Biogen: The Good, the bAD and What's Next
10 Nov 2020
Contributed by Lukas
Reach us by sending a text
Ep. 30 - ICER's Influence and Election Effects
03 Nov 2020
Contributed by Lukas
Reach us by sending a text
Ep. 29 - SPACs & Vax
27 Oct 2020
Contributed by Lukas
Reach us by sending a text
Ep. 28 - FDA's Future & China Summit Preview
20 Oct 2020
Contributed by Lukas
Reach us by sending a text
Ep. 27 - CRISPR advances and mega-IPOs: a BioCentury podcast
13 Oct 2020
Contributed by Lukas
Reach us by sending a text
Ep. 26 - Treating Trump & BMS's $13B MyoKardia buy
06 Oct 2020
Contributed by Lukas
Reach us by sending a text
Ep. 25 - Alzheimer Milestones & Vaccine Politics
29 Sep 2020
Contributed by Lukas
Reach us by sending a text
Ep. 24 - Azar's Memo & Biotech's Deals
22 Sep 2020
Contributed by Lukas
Reach us by sending a text
Ep. 23 - $21B Deal by Gilead, None by PhRMA
15 Sep 2020
Contributed by Lukas
Reach us by sending a text
Ep. 22 - Back to School, Behind the Scenes
09 Sep 2020
Contributed by Lukas
Reach us by sending a text
Ep. 21 - FDA’s Credibility on the Line, plus Biotech’s Venture Wave
01 Sep 2020
Contributed by Lukas
Reach us by sending a text
Ep. 20 - Politics & Plasma
25 Aug 2020
Contributed by Lukas
Reach us by sending a text
Ep. 19 - I Want KaNDy, Plus Sputnik V & M&A amid COVID-19
17 Aug 2020
Contributed by Lukas
Reach us by sending a text
Ep. 18 - BIOEquality, Data Sharing and Deals
10 Aug 2020
Contributed by Lukas
Reach us by sending a text
Ep. 17 - Warp Speed, Decentralized Trials & SPACs
03 Aug 2020
Contributed by Lukas
Reach us by sending a text
Ep. 16 - Trump's Ultimatum, RADx & Preclinical IPOs
27 Jul 2020
Contributed by Lukas
Reach us by sending a text
Ep. 15 - Vaccine Hopes, the Shifting Biopharma Workplace & Blueprint's Dx Deal
21 Jul 2020
Contributed by Lukas
Reach us by sending a text
Ep. 14 - Investor Sentiment, HCQ Redux and Attacking AMR
14 Jul 2020
Contributed by Lukas
Reach us by sending a text
Ep. 13 - Nuances of NASH, COVID Vaccines and Real-World Data
06 Jul 2020
Contributed by Lukas
Reach us by sending a text
Ep. 12 - Remdesivir's Price, RWD’s Moment & A Genomics Breakup
29 Jun 2020
Contributed by Lukas
Reach us by sending a text
Ep. 11 - Funding U.K. Biotechs, plus Global Vaccine Access
23 Jun 2020
Contributed by Lukas
Reach us by sending a text
Ep. 10 - EUAs, ACTIV & M&A
16 Jun 2020
Contributed by Lukas
Reach us by sending a text
Ep. 9 - IPOs, Vaccines & BIO's New Leader
08 Jun 2020
Contributed by Lukas
Reach us by sending a text
Ep. 8 - Financing Flurry & Purchasing Pools
01 Jun 2020
Contributed by Lukas
Reach us by sending a text
Ep. 7 - FDA takes on COVID-19, plus ASCO's breakthroughs
27 May 2020
Contributed by Lukas
Reach us by sending a text
Ep. 6 - New Faces for COVID-19’s Next Phase, ASCO’s Hot Topics
19 May 2020
Contributed by Lukas
Reach us by sending a text
Ep. 5 - Master Protocols, EUAs and Rick Bright: BioCentury editors on COVID-19
12 May 2020
Contributed by Lukas
Reach us by sending a text
Ep. 4 - End of the beginning for vaccines and the post-pandemic future
05 May 2020
Contributed by Lukas
BioCentury editors discuss Goldilocks COVID-19 antibody test regulation, vaccine development, and the post-pandemic future.Reach us by sending a text
Ep. 3 - Surveying the Landscape for Biopharmas
28 Apr 2020
Contributed by Lukas
BioCentury Editors discuss what the latest survey results tell us about how biotechs are managing through the economic downturn, and cover what FDA Co...
Ep. 2 - Consorting to beat COVID-19
23 Apr 2020
Contributed by Lukas
How industry, government and academics are joining together to discover, develop and deploy therapies and vaccines.Reach us by sending a text
Ep. 1 - Racing to Create Countermeasures
22 Apr 2020
Contributed by Lukas
It has been three months since Chinese scientists revealed the genomic sequence of SARS-CoV-2. In our first episode, “Racing to Create Countermeasur...